v3.26.3
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2026
Fair Value Disclosures [Abstract]  
Schedule of Fair Value Hierarchy for Assets and Liabilities Measured at Fair Value on Recurring Basis

The following tables present information about the Company’s financial assets, investments, and financial liabilities measured at fair value on a recurring basis and indicates the level of the fair value hierarchy utilized to determine such fair values:

 

 

As of September 30, 2026:

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents (money market)

 

$

66,668

 

 

$

-

 

 

$

-

 

 

$

66,668

 

Current portion of investments in U.S. Treasury securities

 

 

-

 

 

 

104,562

 

 

 

-

 

 

 

104,562

 

Non-current portion of investments in U.S. Treasury securities

 

 

-

 

 

 

24,353

 

 

 

-

 

 

 

24,353

 

 

$

66,668

 

 

$

128,915

 

 

$

-

 

 

$

195,583

 

 

 

 

As of September 30, 2026:

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Contingent Consideration Liabilities

 

$

-

 

 

$

-

 

 

$

1,267

 

 

$

1,267

 

 

$

-

 

 

$

-

 

 

$

1,267

 

 

$

1,267

 

 

 

 

As of December 31, 2025:

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents (money market)

 

$

40,178

 

 

$

-

 

 

$

-

 

 

$

40,178

 

Current portion of investments in U.S. Treasury securities

 

 

-

 

 

 

118,767

 

 

 

-

 

 

 

118,767

 

Non-current portion of investments in U.S. Treasury securities

 

 

-

 

 

 

64,801

 

 

 

-

 

 

 

64,801

 

 

$

40,178

 

 

$

183,568

 

 

$

-

 

 

$

223,746

 

 

 

 

As of December 31, 2025:

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Contingent Consideration Liabilities

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

Schedule of Investments in U.S. Treasury Securities Classified as Available-for-Sale Securities

Investments in U.S. Treasury securities, which are classified as available-for-sale securities, consisted of the following as of September 30, 2026 and December 31, 2025:

 

 

As of September 30, 2026:

 

 

 

Amortized Cost Basis

 

 

Gross Unrealized Gains

 

 

Gross Unrealized Losses

 

 

Fair Value

 

Available-for-sale securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury securities

 

$

129,380

 

 

$

-

 

 

$

(465

)

 

$

128,915

 

 

$

129,380

 

 

$

-

 

 

$

(465

)

 

$

128,915

 

 

 

 

As of December 31, 2025:

 

 

 

Amortized Cost Basis

 

 

Gross Unrealized Gains

 

 

Gross Unrealized Losses

 

 

Fair Value

 

Available-for-sale securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury securities

 

$

183,380

 

 

$

188

 

 

$

-

 

 

$

183,568

 

 

$

183,380

 

 

$

188

 

 

$

-

 

 

$

183,568

 

Roll Forward of Changes in Fair Value of Financial Liabilities Classified as Level 3

The following table sets forth a roll forward of changes in the fair value of financial liabilities classified as Level 3 in the fair value hierarchy:

 

 

Contingent Consideration Liabilities

 

Beginning balance at December 31, 2025

 

$

-

 

Contingent Consideration Liabilities recognized upon acquisition of Mantle Therapeutics Inc. on September 29, 2026

 

 

1,267

 

Change in estimated fair value since acquisition

 

 

-

 

Ending balance at September 30, 2026

 

$

1,267

 

Significant Unobservable Inputs Used in Valuation Models to Estimate the Fair Value of Contingent Consideration Liabilities The significant unobservable inputs used in the valuation models to estimate the fair value of the Company’s Contingent Consideration Liabilities (as defined below) that were categorized within Level 3 of the fair value hierarchy as of September 29, 2026 (acquisition date) through September 30, 2026 were as follows:

Probability of achieving Equity-based Contingent Consideration milestone

 

 

65

%

 

Probability of achieving Mantle Additional Payment Amount business event

 

 

5

%

 

Time until Equity-based Contingent Consideration milestone event (in years)

 

0.38

 

 

Time until Mantle Additional Payment Amount business event (in years)

 

0.05